1. Home
  2. AXTI vs FBIO Comparison

AXTI vs FBIO Comparison

Compare AXTI & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • FBIO
  • Stock Information
  • Founded
  • AXTI 1986
  • FBIO 2006
  • Country
  • AXTI United States
  • FBIO United States
  • Employees
  • AXTI N/A
  • FBIO N/A
  • Industry
  • AXTI Semiconductors
  • FBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • FBIO Health Care
  • Exchange
  • AXTI Nasdaq
  • FBIO Nasdaq
  • Market Cap
  • AXTI 94.4M
  • FBIO 88.7M
  • IPO Year
  • AXTI 1998
  • FBIO N/A
  • Fundamental
  • Price
  • AXTI $10.18
  • FBIO $2.59
  • Analyst Decision
  • AXTI Strong Buy
  • FBIO Strong Buy
  • Analyst Count
  • AXTI 3
  • FBIO 2
  • Target Price
  • AXTI $7.70
  • FBIO $16.50
  • AVG Volume (30 Days)
  • AXTI 4.2M
  • FBIO 369.7K
  • Earning Date
  • AXTI 10-30-2025
  • FBIO 11-14-2025
  • Dividend Yield
  • AXTI N/A
  • FBIO N/A
  • EPS Growth
  • AXTI N/A
  • FBIO N/A
  • EPS
  • AXTI N/A
  • FBIO N/A
  • Revenue
  • AXTI $90,390,000.00
  • FBIO $62,303,000.00
  • Revenue This Year
  • AXTI N/A
  • FBIO $31.85
  • Revenue Next Year
  • AXTI $32.24
  • FBIO $44.43
  • P/E Ratio
  • AXTI N/A
  • FBIO N/A
  • Revenue Growth
  • AXTI N/A
  • FBIO N/A
  • 52 Week Low
  • AXTI $1.13
  • FBIO $1.33
  • 52 Week High
  • AXTI $11.88
  • FBIO $4.20
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 71.19
  • FBIO 46.44
  • Support Level
  • AXTI $9.24
  • FBIO $2.40
  • Resistance Level
  • AXTI $11.08
  • FBIO $2.76
  • Average True Range (ATR)
  • AXTI 1.22
  • FBIO 0.15
  • MACD
  • AXTI -0.00
  • FBIO 0.03
  • Stochastic Oscillator
  • AXTI 57.35
  • FBIO 56.00

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: